Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Increasing Awareness of Opioid Disposal in the Orthopedic Patient Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03954964
Recruitment Status : Enrolling by invitation
First Posted : May 17, 2019
Last Update Posted : June 18, 2019
Sponsor:
Information provided by (Responsible Party):
Christine D. Aliory, Mayo Clinic

Brief Summary:
Researchers are trying to determine if providing education on proper disposal of unused opioid medications to the orthopedic patient undergoing a planned hip or knee total joint replacement will increase the percentage of patients who properly dispose of unused opioids.

Condition or disease Intervention/treatment Phase
Knee Total Joint Replacement Hip Total Joint Replacement Behavioral: Education on disposal of opioids Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Increasing Awareness of Opioid Disposal in the Orthopedic Patient Population
Actual Study Start Date : June 3, 2019
Estimated Primary Completion Date : November 1, 2019
Estimated Study Completion Date : November 1, 2019

Arm Intervention/treatment
No Intervention: Control Group
Subjects participating in a total joint class for patients undergoing planned hip and knee total joint replacement.
Experimental: Intervention Group
Subjects participating in a total joint class for patients undergoing planned hip and knee total joint replacement will receive additional education about the disposal of opioids.
Behavioral: Education on disposal of opioids
Current class curriculum including education about pain management with additional education about the disposal of opioids.




Primary Outcome Measures :
  1. Disposal of unused prescription pain medication [ Time Frame: 12 weeks post operative ]
    Number of subjects to self-report disposal of unused prescription pain medication on the twelve week post operative visit survey

  2. Use of medication deactivation bag [ Time Frame: 12 weeks post operative ]
    Number of subjects to self-report disposal of unused prescription pain medication via the medication deactivation bag on the twelve week post operative visit survey



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult 18 + years
  • Planned total hip or knee replacement surgery
  • English speaking

Exclusion Criteria:

  • Pediatric patients 17 and younger
  • Non-English speaking patients
  • Total joint replacement surgery other than Hip and Knee

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03954964


Locations
Layout table for location information
United States, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
Sponsors and Collaborators
Mayo Clinic
Investigators
Layout table for investigator information
Principal Investigator: Christine Aliory, APRN Mayo Clinic

Additional Information:
Layout table for additonal information
Responsible Party: Christine D. Aliory, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier: NCT03954964     History of Changes
Other Study ID Numbers: 18-011832
First Posted: May 17, 2019    Key Record Dates
Last Update Posted: June 18, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents